Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia

Journal of Clinical Neuroscience

Volumn 15, Issue 5, 2008, Pages 516-519

  Gomez Arguelles, J M ^a   Dorado, R ^a,b   Sepulveda, J M ^a   Herrera, A ^a   Gilo Arrojo, F ^a,b   Aragon E ^a   Ruiz Huete, C ^a   Terron C ^a   Anciones, B ^a,b  

^a Unidad de Imagen   (Spain)

^b Hospital de la Zarzuela   (Spain)

Author keywords

Antiepileptic drug; Carbamazepine; Oxcarbazepine; Trigeminal neuralgia

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMPARATIVE STUDY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; HYPONATREMIA; MALE; MONOTHERAPY; NAUSEA; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOMNOLENCE; TRIGEMINUS NEURALGIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TRIGEMINAL NEURALGIA;

EID: 41549084998     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.04.010     Document Type: Article

References (29)

1. Katusic S., Williams D.B., Beard C.M., et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 10 (1991) 276-281
2. Katusic S., Beard C.M., Bergstralh E.J., et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 27 (1990) 89-95
3. Love S., and Coakham H.B. Trigeminal neuralgia: pathology and pathogenesis. Brain 124 (2001) 2347-2360
4. Backonja M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 59 Suppl. 2 (2002) S14-S17
5. Sindrup S.H., and Jensen T.S. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 18 (2002) 22-27
6. Burcheil K.J. Trigeminal neuralgia. In: Rakel R.E. (Ed). Conn's Current Therapy (1999), WB Saunders, Philadelphia 948-950
7. Attal N., Cruccu G., Haanpaa M., et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
8. Peiris J.B., Perera G.L., Devendra S.V., et al. Sodium valproate in trigeminal neuralgia. Med J Aust 2 (1980) 278
9. Cheshire Jr. W.P. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain 3 (2002) 137-142
10. Khan O.A. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51 (1998) 611-614
11. Sist T., Filadora V., Miner M., et al. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 48 (1997) 1467
12. Leandri M., Lundardi G., Inglese M., et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol 247 (2000) 556-558
13. Carrazana E.J., and Schachter S.C. Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia. Neurology 50 (1998) 1192
14. Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73 (1997) 223-230
15. Canavero S., and Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J Neurol 244 (1997) 527
16. Lunardi G., Leandri M., Albano C., et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48 (1997) 1714-1717
17. Canavero S., Bonicalzi V., Ferroli P., et al. Lamotrigine control of idiopathic trigeminal neuralgia. J Neurol Neurosurg Psychiatry 59 (1995) 646
18. Solaro C., Uccelli M.M., Brichetto G., et al. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage 21 (2001) 367-368
19. Zvartau-Hind M., Din M.U., Gilani A., et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55 (2000) 1587-1588
20. Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 26 (1987) 73-83
21. Zakrzewska J.M., and Patsalos P.N. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry 52 (1989) 472-476
22. Zakrzewska J.M., and Patsalos P.N. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 95 (2002) 259-266
23. Beydoum A., Arbor A., and Schmidt D. Oxcarbazepine versus carmabazepine in trigeminal neuralgia: a meta-analysis of three double-blind comparative trials. Neurology 58 Suppl. 3 (2002) 131
24. Lidstrom P. The analgesic effect of carbamazepine in trigeminal neuralgia. Pain 4 (1987) S85
25. Dong X., Leppik I.E., White J., et al. Hyponatremia from oxcarbazepine and carbamazepine. Neurology 65 (2005) 1976-1978
26. Friis M.L., Kristensen O., Boas J., et al. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87 (1993) 224-227
27. Carrazana E., and Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 25 Suppl. 5 (2003) S31-S35
28. Grant S.M., and Faulds D. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 43 (1992) 873-888
29. Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 20 (2000) 152S-158S